-transparent.png){kind=logo}
The induction of chromosomal damage (sister chromatid exchanges (SCEs), chromosomal aberrations, and micronuclei) in T lymphocytes from mouse spleen was analyzed after treatment in vivo with different concentrations of mitomycin C (MMC). Lymphocytes were derived from BALB/Mo mice, which carry an endogenous type C retrovirus (Moloney murine leukemia virus, M-MuLV), and from BALB/c mice (controls, M-MuLV-free). Chromosomal damage was determined in vitro on lymphocytes stimulated with concanavalin A (Con A) and incubated for two generation cycles with bromodeoxyuridine (BUdR). The baseline frequency of SCEs was significantly higher in untreated BALB/Mo than in BALB/c lymphocytes. The frequencies of SCEs were significantly increased by increasing doses of MMC in both BALB/c and BALB/Mo T lymphocytes. Treatment with a low dose of MMC (0.3 mg/kg) produced an additive effect on SCE frequency in BALB/Mo lymphocytes, which was gradually suppressed by increasing the MMC concentration (3-5 mg/kg). Indeed, the levels of SCEs became significantly lower in BALB/Mo than in BALB/c lymphocytes at the highest MMC concentration tested (10 mg/kg), indicating that a negative synergistic effect was eventually produced. Chromosomal aberrations (breaks and total aberrations) were significantly increased by the highest MMC doses (5-10 mg/kg) and were more frequent in BALB/Mo than in BALB/c lymphocytes at 10 mg/kg MMC. The frequencies of micronuclei were increased by all MMC doses and were significantly higher in BALB/Mo than in BALB/c lymphocytes at 10 mg/kg MMC. These results are referred to interferences of M-MuLV and MMC with the function of enzymes, such as DNA topoisomerases, involved in the mechanism of SCE production.
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
June 2006,
Cytotechnology,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
June 1987,
Mutation research,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
September 1988,
Mutation research,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
January 1994,
Yi chuan xue bao = Acta genetica Sinica,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
January 1987,
Neoplasma,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
March 1988,
International journal of cancer,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
January 1984,
Human genetics,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
April 1986,
The Indian journal of medical research,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
February 1992,
Journal of toxicology and environmental health,
F Majone, and
A Montaldi, and
F Ronchese, and
V Bianchi, and
A G Levis
June 1975,
Mutation research,
